Biomea Fusion, Inc. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax
Biomea Fusion, Inc. (BMEA) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax of $0 as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax $0.00.
- 2026-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax $0.00.
- 2025-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax $0.00.
- 2025-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax $0.00.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-05 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-05 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-24 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-29 |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-31 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-30 |
| 2023-06-30 | $0.00 10-Q · filed 2023-07-31 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-02 |
| 2022-12-31 | $0.00 10-Q · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |